Controlled release strategies for bone, cartilage, and osteochondral engineering-part ii: Challenges on the evolution from single to multiple bioactive factor delivery

Tissue Engineering - Part B: Reviews

Volumn 19, Issue 4, 2013, Pages 327-352

  Santo, Vítor E ^a   Gomes, Manuela E ^a   Mano, João F ^a   Reis, Rui L ^a  

^a UNIVERSITY OF MINHO   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE FACTOR; BIOLOGICAL RESPONSE; CONTROLLED RELEASE; CONTROLLED RELEASE SYSTEMS; EXTRACELLULAR MATRICES; PLATELET RICH PLASMA; REGENERATIVE MEDICINE; SPATIOTEMPORAL DISTRIBUTIONS;

BIOLOGY; BONE; CARTILAGE; TISSUE REGENERATION;

BIOACTIVITY;

BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 2; OSTEOGENIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN C; STROMAL CELL DERIVED FACTOR 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANGIOGENESIS; BONE; CARTILAGE; CONTROLLED RELEASE FORMULATION; DRUG DELIVERY SYSTEM; HUMAN; IMPLANTATION; NANOENCAPSULATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SPATIOTEMPORAL ANALYSIS; THROMBOCYTE RICH PLASMA; TISSUE ENGINEERING;

ANIMALS; BONE AND BONES; BONE SUBSTITUTES; CARTILAGE; CYTOKINES; DRUG DELIVERY SYSTEMS; HUMANS; OSSEOINTEGRATION;

EID: 84877969932     PISSN: 19373368     EISSN: 19373376     Source Type: Journal    
DOI: 10.1089/ten.teb.2012.0727     Document Type: Review

References (339)

1. Smith, J.O., Aarvold, A., Tayton, E.R., Dunlop, D.G., and Oreffo, R.O. Skeletal tissue regeneration: current approaches, challenges, and novel reconstructive strategies for an aging population. Tissue Eng Part B Rev 17, 307, 2011.
2. Wang, W., Li, B., Yang, J., Xin, L., Li, Y., Yin, H., et al. The restoration of full-thickness cartilage defects with BMSCs and TGF-beta 1 loaded PLGA/fibrin gel constructs. Bio-materials 31, 8964, 2010.
3. Choi, S.J., Na, K., Kim, S., Woo, D.G., Sun, B.K., Chung, H.M., et al. Combination of ascorbate and growth factor (TGF beta-3) in thermo-reversible hydrogel constructs embedded with rabbit chondrocytes for neocartilage formation. J Biomed Mater Res A 83, 897, 2007.
4. Na, K., Kim, S., Woo, D.G., Sun, B.K., Yang, H.N., Chung, H.M., et al. Combination material delivery of dexametha-sone and growth factor in hydrogel blended with hya-luronic acid constructs for neocartilage formation. J Biomed Mater Res A 83, 779, 2007.
5. Fortier, L.A., Mohammed, H.O., Lust, G., and Nixon, A.J. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 84, 276, 2002.
6. Na, K., Kim, S.W., Sun, B.K., Woo, D.G., Yang, H.N., Chung, H.M., et al. Osteogenic differentiation of rabbit mesenchymal stem cells in thermo-reversible hydrogel constructs containing hydroxyapatite and bone morpho-genic protein-2 (BMP-2). Biomaterials 28, 2631, 2007.
7. Kim, J., Kim, I.S., Cho, T.H., Lee, K.B., Hwang, S.J., Tae, G., et al. Bone regeneration using hyaluronic acid-based hy-drogel with bone morphogenic protein-2 and human mesenchymal stem cells. Biomaterials 28, 1830, 2007.
8. Rocha, P.M., Santo, V.E., Gomes, M.E., Reis, R.L., and Mano, J.F. Encapsulation of adipose-derived stem cells and transforming growth factor-beta 1 in carrageenan-based hydrogels for cartilage tissue engineering. J Bioact Compat Polym 26, 493, 2011.
9. Park, D.J., Choi, B.H., Zhu, S.J., Huh, J.Y., Kim, B.Y., and Lee, S.H. Injectable bone using chitosan-alginate gel/mes-enchymal stem cells/BMP-2 composites. J Craniomaxillofac Surg 33, 50, 2005.
10. Miller, R.E., Grodzinsky, A.J., Vanderploeg, E.J., Lee, C., Ferris, D.J., Barrett, M.F., et al. Effect of self-assembling peptide, chondrogenic factors, and bone marrow-derived stromal cells on osteochondral repair. Osteoarthritis Cartilage 18, 1608, 2010.
11. Park, J.S., Na, K., Woo, D.G., Yang, H.N., and Park, K.H. Determination of dual delivery for stem cell differentiation using dexamethasone and TGF-beta3 in/on polymeric mi-crospheres. Biomaterials 30, 4796, 2009.
12. Yilgor, P., Tuzlakoglu, K., Reis, R.L., Hasirci, N., and Ha-sirci, V. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 30, 3551, 2009.
13. Yilgor, P., Sousa, R.A., Reis, R.L., Hasirci, N., and Hasirci, V. Effect of scaffold architecture and BMP-2/BMP-7 delivery on in vitro bone regeneration. J Mater Sci Mater Med 21, 2999, 2010.
14. Lee, J.W., Kang, K.S., Lee, S.H., Kim, J.Y., Lee, B.K., and Cho, D.W. Bone regeneration using a micro-stereolithography-produced customized poly(propylene fumarate)/diethyl fumarate photopolymer 3D scaffold incorporating BMP-2 loaded PLGA microspheres. Biomater-ials 32, 744, 2011.
15. Park, J.S., Yang, H.N., Jeon, S.Y., Woo, D.G., Na, K., and Park, K.H. Osteogenic differentiation of human mesen-chymal stem cells using RGD-modified BMP-2 coated mi-crospheres. Biomaterials 31, 6239, 2010.
16. Lee, J.Y., Seol, Y.J., Kim, K.H., Lee, Y.M., Park, Y.J., Rhyu, I.C., et al. Transforming growth factor (TGF)-beta1 releasing tricalcium phosphate/chitosan microgranules as bone substitutes. Pharm Res 21, 1790, 2004.
17. Chen, F.M., Chen, R., Wang, X.J., Sun, H.H., and Wu, Z.F. In vitro cellular responses to scaffolds containing two microencapulated growth factors. Biomaterials 30, 5215, 2009.
18. Kanczler, J.M., Ginty, P.J., White, L., Clarke, N.M., Howdle, S.M., Shakesheff, K.M., et al. The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. Biomaterials 31, 1242, 2010.
19. Solorio, L.D., Vieregge, E.L., Dhami, C.D., Dang, P.N., and Alsberg, E. Engineered cartilage via self-assembled hMSC sheets with incorporated biodegradable gelatin microspheres releasing transforming growth factor-beta1. J Control Release 158, 224, 2011.
20. Han, Y., Wei, Y., Wang, S., and Song, Y. Cartilage regeneration using adipose-derived stem cells and the con-trolled-released hybrid microspheres. Joint Bone Spine 77, 27, 2010.
21. Bouffi, C., Thomas, O., Bony, C., Giteau, A., Venier-Ju-lienne, M.C., Jorgensen, C., et al. The role of pharmacologically active microcarriers releasing TGF-beta3 in cartilage formation in vivo by mesenchymal stem cells. Biomaterials 31, 6485, 2010.
22. Jha, A.K., Yang, W., Kirn-Safran, C.B., Farach-Carson, M.C., and Jia, X. Perlecan domain I-conjugated, hyaluronic acid-based hydrogel particles for enhanced chondrogenic differentiation via BMP-2 release. Biomaterials 30, 6964, 2009.
23. Fan, H., Zhang, C., Li, J., Bi, L., Qin, L., Wu, H., et al. Gelatin microspheres containing TGF-beta3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. Biomacromolecules 9, 927, 2008.
24. Chen, F.M., Zhao, Y.M., Wu, H., Deng, Z.H., Wang, Q.T., Zhou, W., et al. Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres. J Control Release 114, 209, 2006.
25. Meinel, L., Zoidis, E., Zapf, J., Hassa, P., Hottiger, M.O., Auer, J.A., et al. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33, 660, 2003.
26. Bessa, P.C., Balmayor, E.R., Hartinger, J., Zanoni, G., Do-pler, D., Meinl, A., et al. Silk fibroin microparticles as carriers for delivery of human recombinant bone morphogenetic protein-2: in vitro and in vivo bioactivity. Tissue Eng Part C Methods 16, 937, 2010.
27. Xu, X., Jha, A.K., Duncan, R.L., and Jia, X. Heparin-deco-rated, hyaluronic acid-based hydrogel particles for the controlled release of bone morphogenetic protein 2. Acta Biomater 7, 3050, 2011.
28. Khan, A.A., Paul, A., Abbasi, S., and Prakash, S. Mitotic and antiapoptotic effects of nanoparticles coencapsulating human VEGF and human angiopoietin-1 on vascular en-dothelial cells. Int J Nanomedicine 6, 1069, 2011.
29. Matsuo, T., Sugita, T., Kubo, T., Yasunaga, Y., Ochi, M., and Murakami, T. Injectable magnetic liposomes as a novel carrier of recombinant human BMP-2 for bone formation in a rat bone-defect model. J Biomed Mater Res A 66, 747, 2003.
30. Mercado, A.E., Ma, J., He, X., and Jabbari, E. Release characteristics and osteogenic activity of recombinant human bone morphogenetic protein-2 grafted to novel self-assembled poly(lactide-co-glycolide fumarate) nano-particles. J Control Release 140, 148, 2009.
31. Oda, S., Nagahama, R., Nakano, K., Matoba, T., Kubo, M., Sunagawa, K., et al. Nanoparticle-mediated endothelial cell-selective delivery of pitavastatin induces functional collateral arteries (therapeutic arteriogenesis) in a rabbit model of chronic hind limb ischemia. J Vasc Surg 52, 412, 2010.
32. Lee, J.E., Kim, K.E., Kwon, I.C., Ahn, H.J., Lee, S.H., Cho, H., et al. Effects of the controlled-released TGF-beta 1 from chitosan microspheres on chondrocytes cultured in a col-lagen/chitosan/glycosaminoglycan scaffold. Biomaterials 25, 4163, 2004.
33. Fan, H., Hu, Y., Qin, L., Li, X., Wu, H., and Lv, R. Porous gelatin-chondroitin-hyaluronate tri-copolymer scaffold containing microspheres loaded with TGF-beta1 induces differentiation of mesenchymal stem cells in vivo for enhancing cartilage repair. J Biomed Mater Res A 77, 785, 2006.
34. Park, H., Temenoff, J.S., Tabata, Y., Caplan, A.I., and Mi-kos, A.G. Injectable biodegradable hydrogel composites for rabbit marrow mesenchymal stem cell and growth factor delivery for cartilage tissue engineering. Biomaterials 28, 3217, 2007.
35. Park, H., Temenoff, J.S., Holland, T.A., Tabata, Y., and Mikos, A.G. Delivery of TGF-b1 and chondrocytes via in-jectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials 26, 7095, 2005.
36. Bian, L., Zhai, D.Y., Tous, E., Rai, R., Mauck, R.L., and Burdick, J.A. Enhanced MSC chondrogenesis following delivery of TGF-beta3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo. Biomaterials 32, 6425, 2011.
37. Park, H., Temenoff, J.S., Tabata, Y., Caplan, A.I., Raphael, R.M., Jansen, J.A., et al. Effect of dual growth factor delivery on chondrogenic differentiation of rabbit marrow mesen-chymal stem cells encapsulated in injectable hydrogel composites. J Biomed Mater Res A 88, 889, 2009.
38. DeFail, A.J., Chu, C.R., Izzo, N., and Marra, K.G. Controlled release of bioactive TGF-beta 1 from microspheres embedded within biodegradable hydrogels. Biomaterials 27, 1579, 2006.
39. Giannoni, P., and Hunziker, E.B. Release kinetics of transforming growth factor-beta1 from fibrin clots. Biotechnol Bioeng 83, 121, 2003.
40. Sukarto, A., and Amsden, B.G. Low melting point amphi-philic microspheres for delivery of bone morphogenetic protein-6 and transforming growth factor-beta3 in a hy-drogel matrix. J Control Release 158, 53, 2011.
41. Spiller, K.L., Liu, Y., Holloway, J.L., Maher, S.A., Cao, Y., Liu, W., et al. A novel method for the direct fabrication of growth factor-loaded microspheres within porous nonde-gradable hydrogels: controlled release for cartilage tissue engineering. J Control Release 157, 39, 2011.
42. Lee, M., Li, W., Siu, R.K., Whang, J., Zhang, X., Soo, C., et al. Biomimetic apatite-coated alginate/chitosan microparticles as osteogenic protein carriers. Biomaterials 30, 6094, 2009.
43. Li, B., Yoshii, T., Hafeman, A.E., Nyman, J.S., Wenke, J.C., and Guelcher, S.A. The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora. Biomaterials 30, 6768, 2009.
44. Richardson, T.P., Peters, M.C., Ennett, A.B., and Mooney, D.J. Polymeric system for dual growth factor delivery. Nat Biotechnol 19, 1029, 2001.
45. Patel, Z.S., Young, S., Tabata, Y., Jansen, J.A., Wong, M.E., and Mikos, A.G. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43, 931, 2008.
46. Patel, Z.S., Yamamoto, M., Ueda, H., Tabata, Y., and Mikos, A.G. Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 4, 1126, 2008.
47. Jeon, O., Kang, S.W., Lim, H.W., Hyung Chung, J., and Kim, B.S. Long-term and zero-order release of basic fibro-blast growth factor from heparin-conjugated poly(L-lactide-co-glycolide) nanospheres and fibrin gel. Biomaterials 27, 1598, 2006.
48. Jung, Y., Chung, Y.I., Kim, S.H., Tae, G., Kim, Y.H., and Rhie, J.W. In situ chondrogenic differentiation of human adipose tissue-derived stem cells in a TGF-beta1 loaded fibrin-poly(lactide-caprolactone) nanoparticulate complex. Biomaterials 30, 4657, 2009.
49. Nie, H., and Wang, C-H. Fabrication and characterization of PLGA/HAp composite scaffolds for delivery of BMP-2 plasmid DNA. J Control Release 120, 111, 2007.
50. Wei, G., Jin, Q., Giannobile, W.V., and Ma, P.X. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 28, 2087, 2007.
51. Park, J.S., Woo, D.G., Yang, H.N., Na, K., and Park, K.H. Transforming growth factor beta-3 bound with sulfate polysaccharide in synthetic extracellular matrix enhanced the biological activities for neocartilage formation in vivo. J Biomed Mater Res A 91, 408, 2009.
52. Kopesky, P.W., Vanderploeg, E.J., Kisiday, J.D., Frisbie, D.D., Sandy, J.D., and Grodzinsky, A.J. Controlled delivery of transforming growth factor beta1 by self-assembling peptide hydrogels induces chondrogenesis of bone marrow stromal cells and modulates Smad2/3 signaling. Tissue Eng Part A 17, 83, 2011.
53. Park, J.S., Shim, M.S., Shim, S.H., Yang, H.N., Jeon, S.Y., Woo, D.G., et al. Chondrogenic potential of stem cells derived from amniotic fluid, adipose tissue, or bone marrow encapsulated in fibrin gels containing TGF-beta3. Bioma-terials 32, 8139, 2011.
54. Mullen, L.M., Best, S.M., Brooks, R.A., Ghose, S., Gwynne, J.H., Wardale, J., et al. Binding and release characteristics of insulin-like growth factor-1 from a collagen-glycosamino-glycan scaffold. Tissue Eng Part C Methods 16, 1439, 2010.
55. Park, K.H., and Na, K. Effect of growth factors on chon-drogenic differentiation of rabbit mesenchymal cells embedded in injectable hydrogels. J Biosci Bioeng 106, 74, 2008.
56. Jung, H.H., Park, K., and Han, D.K. Preparation of TGF-beta1-conjugated biodegradable pluronic F127 hydrogel and its application with adipose-derived stem cells. J Control Release 147, 84, 2010.
57. Yang, H.S., La, W.G., Bhang, S.H., Kim, H.J., Im, G.I., Lee, H., et al. Hyaline cartilage regeneration by combined therapy of microfracture and long-term bone morphogenetic protein-2 delivery. Tissue Eng Part A 17, 1809, 2011.
58. Takahashi, Y., Yamamoto, M., and Tabata, Y. Enhanced osteoinduction by controlled release of bone morphoge-netic protein-2 from biodegradable sponge composed of gelatin and beta-tricalcium phosphate. Biomaterials 26, 4856, 2005.
59. Kolambkar, Y.M., Dupont, K.M., Boerckel, J.D., Huebsch, N., Mooney, D.J., Hutmacher, D.W., et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. Biomaterials 32, 65, 2011.
60. Ripamonti, U., Klar, R.M., Renton, L.F., and Ferretti, C. Synergistic induction of bone formation by hOP-1, hTGF-beta3 and inhibition by zoledronate in macroporous coral-derived hydroxyapatites. Biomaterials 31, 6400, 2010.
61. Luvizuto, E.R., Tangl, S., Zanoni, G., Okamoto, T., Sonoda, C.K., Gruber, R., et al. The effect of BMP-2 on the osteo-conductive properties of beta-tricalcium phosphate in rat calvaria defects. Biomaterials 32, 3855, 2011.
62. Lee, J.H., Kim, C.S., Choi, K.H., Jung, U.W., Yun, J.H., Choi, S.H., et al. The induction of bone formation in rat calvarial defects and subcutaneous tissues by recombinant human BMP-2, produced in Escherichia coli. Biomaterials 31, 3512, 2010.
63. Higashino, K., Viggeswarapu, M., Bargouti, M., Liu, H., Titus, L., and Boden, S.D. Stromal cell-derived factor-1 potentiates bone morphogenetic protein-2 induced bone formation. Tissue Eng Part A 17, 523, 2011.
64. Kanakaris, N.K., Calori, G.M., Verdonk, R., Burssens, P., De Biase, P., Capanna, R., et al. Application of BMP-7 to tibial non-unions: a 3-year multicenter experience. Injury 39 Suppl 2, S83, 2008.
65. Luca, L., Rougemont, A.L., Walpoth, B.H., Gurny, R., and Jordan, O. The effects of carrier nature and pH on rhBMP-2-induced ectopic bone formation. J Control Release 147, 38, 2010.
66. Jeon, O., Song, S.J., Kang, S.W., Putnam, A.J., and Kim, B.S. Enhancement of ectopic bone formation by bone morpho-genetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. Biomaterials 28, 2763, 2007.
67. Catelas, I., Dwyer, J.F., and Helgerson, S. Controlled release of bioactive transforming growth factor beta-1 from fibrin gels in vitro. Tissue Eng Part C Methods 14, 119, 2008.
68. Kim, C.S., Kim, J.I., Kim, J., Choi, S.H., Chai, J.K., Kim, C.K., et al. Ectopic bone formation associated with recom-binant human bone morphogenetic proteins-2 using ab-sorbable collagen sponge and beta tricalcium phosphate as carriers. Biomaterials 26, 2501, 2005.
69. Jeon, O., Powell, C., Solorio, L.D., Krebs, M.D., and Als-berg, E. Affinity-based growth factor delivery using biodegradable, photocrosslinked heparin-alginate hydrogels. J Control Release 154, 258, 2011.
70. Jeon, O., Song, S.J., Yang, H.S., Bhang, S.H., Kang, S.W., Sung, M.A., et al. Long-term delivery enhances in vivo oste-ogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. Biochem Biophys Res Commun 369, 774, 2008.
71. Nillesen, S.T., Geutjes, P.J., Wismans, R., Schalkwijk, J., Daamen, W.F., and van Kuppevelt, T.H. Increased angio-genesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Bio-materials 28, 1123, 2007.
72. Pike, D.B., Cai, S., Pomraning, K.R., Firpo, M.A., Fisher, R.J., Shu, X.Z., et al. Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hya-luronan hydrogels containing VEGF and bFGF. Biomaterials 27, 5242, 2006.
73. Lieberman, J.R., Daluiski, A., and Einhorn, T.A. The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A, 1032, 2002.
74. Herford, A.S., and Boyne, P.J. Reconstruction of mandibu-lar continuity defects with bone morphogenetic protein-2 (rhBMP-2). J Oral Maxillofac Surg 66, 616, 2008.
75. Boyne, P.J., Lilly, L.C., Marx, R.E., Moy, P.K., Nevins, M., Spagnoli, D.B., et al. De novo bone induction by recombi-nant human bone morphogenetic protein-2 (rhBMP-2) in maxillary sinus floor augmentation. J Oral Maxillofac Surg 63, 1693, 2005.
76. Burkus, J.K., Gornet, M.F., Dickman, C.A., and Zdeblick, T.A. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 15, 337, 2002.
77. Burkus, J.K., Transfeldt, E.E., Kitchel, S.H., Watkins, R.G., and Balderston, R.A. Clinical and radiographic outcomes of anterior lumbar interbody fusion using recombinant human bone morphogenetic protein-2. Spine (Phila Pa 1976) 27, 2396, 2002.
78. Friedlaender, G.E., Perry, C.R., Cole, J.D., Cook, S.D., Cierny, G., Muschler, G.F., et al. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A Suppl 1, S151, 2001.
79. Vaccaro, A.R., Anderson, D.G., Patel, T., Fischgrund, J., Truumees, E., Herkowitz, H.N., et al. Comparison of OP-1 Putty (rhBMP-7) to iliac crest autograft for posterolateral lumbar arthrodesis: a minimum 2-year follow-up pilot study. Spine (Phila Pa 1976) 30, 2709, 2005.
80. Bessa, P.C., Casal, M., and Reis, R.L. Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery). J Tissue Eng Regen Med 2, 81, 2008.
81. Hollister, S.J., and Murphy, W.L. Scaffold translation: barriers between concept and clinic. Tissue Eng Part B Rev 17, 459, 2011.
82. Senta, H., Park, H., Bergeron, E., Drevelle, O., Fong, D., Leblanc, E., et al. Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations. Cytokine Growth Factor Rev 20, 213, 2009.
83. Schuckert, K.H., Jopp, S., and Osadnik, M. Modern bone regeneration instead of bone transplantation: a combination of recombinant human bone morphogenetic protein-2 and platelet-rich plasma for the vertical augmentation of the maxillary bone- A single case report. Tissue Eng Part C Methods 16, 1335, 2010.
84. Cao, L., and Mooney, D.J. Spatiotemporal control over growth factor signaling for therapeutic neovascularization. Adv Drug Deliv Rev 59, 1340, 2007.
85. Collen, A., Koolwijk, P., Kroon, M., and van Hinsbergh, V.W. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvas-cular endothelial cells. Angiogenesis 2, 153, 1998.
86. Shen, Y.H., Shoichet, M.S., and Radisic, M. Vascular en-dothelial growth factor immobilized in collagen scaffold promotes penetration and proliferation of endothelial cells. Acta Biomater 4, 477, 2008.
87. Jadhav, U., Chigurupati, S., Lakka, S.S., and Mohanam, S. Inhibition of matrix metalloproteinase-9 reduces in vitro invasion and angiogenesis in human microvascular endo-thelial cells. Int J Oncol 25, 1407, 2004.
88. Ozawa, C.R., Banfi, A., Glazer, N.L., Thurston, G., Springer, M.L., Kraft, P.E., et al. Microenvironmental VEGF concentration, not total dose, determines a threshold between normal and aberrant angiogenesis. J Clin Invest 113, 516, 2004.
89. Hankenson, K.D., Dishowitz, M., Gray, C., and Schenker, M. Angiogenesis in bone regeneration. Injury 42, 556, 2011.
90. Taylor, D.K., Meganck, J.A., Terkhorn, S., Rajani, R., Naik, A., O'Keefe, R.J., et al. Thrombospondin-2 influences the proportion of cartilage and bone during fracture healing. J Bone Miner Res 24, 1043, 2009.
91. Liu, Y., Lu, Y., Tian, X., Cui, G., Zhao, Y., Yang, Q., et al. Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model. Biomaterials 30, 6276, 2009.
92. Yang, H.S., La, W.G., Bhang, S.H., Lee, T.J., Lee, M., and Kim, B.S. Apatite-coated collagen scaffold for bone mor-phogenetic protein-2 delivery. Tissue Eng Part A 17, 2153, 2011.
93. Kim, I.S., Lee, E.N., Cho, T.H., Song, Y.M., Hwang, S.J., Oh, J.H., et al. Promising efficacy of Escherichia coli recombinant human bone morphogenetic protein-2 in collagen sponge for ectopic and orthotopic bone formation and comparison with mammalian cell recombinant human bone morpho-genetic protein-2. Tissue Eng Part A 17, 337, 2011.
94. Brown, K.V., Li, B., Guda, T., Perrien, D.S., Guelcher, S.A., and Wenke, J.C. Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic pro-tein-2 release. Tissue Eng Part A 17, 1735, 2011.
95. Fu, Y.C., Nie, H., Ho, M.L., Wang, C.K., and Wang, C.H. Optimized bone regeneration based on sustained release from three-dimensional fibrous PLGA/HAp composite scaffolds loaded with BMP-2. Biotechnol Bioeng 99, 996, 2008.
96. Bae, J.H., Song, H.R., Kim, H.J., Lim, H.C., Park, J.H., Liu, Y., et al. Discontinuous release of bone morphogenetic protein-2 loaded within interconnected pores of honeycomb-like polycaprolactone scaffold promotes bone healing in a large bone defect of rabbit ulna. Tissue Eng Part A 17, 2389, 2011.
97. Zhao, J., Shinkai, M., Takezawa, T., Ohba, S., Chung, U.I., and Nagamune, T. Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2. J Biosci Bioeng 107, 318, 2009.
98. Schmoekel, H.G., Weber, F.E., Schense, J.C., Gratz, K.W., Schawalder, P., and Hubbell, J.A. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. Biotechnol Bioeng 89, 253, 2005.
99. Kolambkar, Y.M., Boerckel, J.D., Dupont, K.M., Bajin, M., Huebsch, N., Mooney, D.J., et al. Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. Bone 49, 485, 2011.
100. Tan, R., She, Z., Wang, M., Yu, X., Jin, H., and Feng, Q. Repair of rat calvarial bone defects by controlled release of rhBMP-2 from an injectable bone regeneration composite. J Tissue Eng Regen Med 6, 614, 2011.
101. Kempen, D.H., Lu, L., Hefferan, T.E., Creemers, L.B., Maran, A., Classic, K.L., et al. Retention of in vitro and in vivo BMP-2 bioactivities in sustained delivery vehicles for bone tissue engineering. Biomaterials 29, 3245, 2008.
102. Kodama, N., Nagata, M., Tabata, Y., Ozeki, M., Ninomiya, T., and Takagi, R. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. Bone 44, 699, 2009.
103. Chen, W-J., Jingushi, S., Aoyama, I., Anzai, J., Hirata, G., Tamura, M., et al. Effects of FGF-2 on metaphyseal fracture repair in rabbit tibiae. J Bone Miner Metab 22, 303, 2004.
104. Kawaguchi, H., Nakamura, K., Tabata, Y., Ikada, Y., Aoyama, I., Anzai, J., et al. Acceleration of fracture healing in nonhuman primates by fibroblast growth factor-2. J Clin Endocrinol Metab 86, 875, 2001.
105. Kawaguchi, H., Oka, H., Jingushi, S., Izumi, T., Fukunaga, M., Sato, K., et al. A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: a randomized, placebo-controlled trial. J Bone Miner Res 25, 2735, 2010.
106. Yamamoto, M., Takahashi, Y., and Tabata, Y. Enhanced bone regeneration at a segmental bone defect by controlled release of bone morphogenetic protein-2 from a biodegradable hydrogel. Tissue Eng 12, 1305, 2006.
107. Nair, A., Thevenot, P., Dey, J., Shen, J., Sun, M.W., Yang, J., et al. Novel polymeric scaffolds using protein microbubbles as porogen and growth factor carriers. Tissue Eng Part C Methods 16, 23, 2010.
108. Vehof, J.W.M., Fisher, J.P., Dean, D., van der Waerden, J-P.C.M., Spauwen, P.H.M., Mikos, A.G., et al. Bone formation in transforming growth factor b-1-coated porous poly(propylene fumarate) scaffolds. J Biomed Mater Res 60, 241, 2002.
109. Burastero, G., Scarfi, S., Ferraris, C., Fresia, C., Sessarego, N., Fruscione, F., et al. The association of human mesen-chymal stem cells with BMP-7 improves bone regeneration of critical-size segmental bone defects in athymic rats. Bone 47, 117, 2010.
110. Al-Zube, L., Breitbart, E.A., O'Connor, J.P., Parsons, J.R., Bradica, G., Hart, C.E., et al. Recombinant human platelet-derived growth factor BB (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic rat model. J Orthop Res 27, 1074, 2009.
111. Hollinger, J.O., Onikepe, A.O., MacKrell, J., Einhorn, T., Bradica, G., Lynch, S., et al. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-bb and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26, 83, 2008.
112. Jeong Park, Y., Moo Lee, Y., Nae Park, S., Yoon Sheen, S., Pyoung Chung, C., and Lee, S.J. Platelet derived growth factor releasing chitosan sponge for periodontal bone regeneration. Biomaterials 21, 153, 2000.
113. Silva, E.A., and Mooney, D.J. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis. J Thromb Haemost 5, 590, 2007.
114. Chen, R.R., Silva, E.A., Yuen, W.W., Brock, A.A., Fisch-bach, C., Lin, A.S., et al. Integrated approach to designing growth factor delivery systems. FASEB J 21, 3896, 2007.
115. Chung, Y.I., Kim, S.K., Lee, Y.K., Park, S.J., Cho, K.O., Yuk, S.H., et al. Efficient revascularization by VEGF administration via heparin- functionalized nanoparticle-fibrin complex. J Control Release 143, 282, 2010.
116. Ehrbar, M., Djonov, V.G., Schnell, C., Tschanz, S.A., Mar-tiny-Baron, G., Schenk, U., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 94, 1124, 2004.
117. Perets, A., Baruch, Y., Weisbuch, F., Shoshany, G., Neufeld, G., and Cohen, S. Enhancing the vascularization of three-dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor micro-spheres. J Biomed Mater Res A 65, 489, 2003.
118. Hosseinkhani, H., Hosseinkhani, M., Khademhosseini, A., Kobayashi, H., and Tabata, Y. Enhanced angiogenesis through controlled release of basic fibroblast growth factor from peptide amphiphile for tissue regeneration. Bioma-terials 27, 5836, 2006.
119. Dickhut, A., Dexheimer, V., Martin, K., Lauinger, R., Hei-sel, C., and Richter W. Chondrogenesis of human mesen-chymal stem cells by local transforming growth factor-beta delivery in a biphasic resorbable carrier. Tissue Eng Part A 16, 453, 2010.
120. Guo, X., Park, H., Young, S., Kretlow, J.D., van den Beucken, J.J., Baggett, L.S., et al. Repair of osteochondral defects with biodegradable hydrogel composites encapsulating marrow mesenchymal stem cells in a rabbit model. Acta Biomater 6, 39, 2010.
121. Guo, X., Liao, J., Park, H., Saraf, A., Raphael, R.M., Ta-bata, Y., et al. Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite. Acta Biomater 6, 2920, 2010.
122. Huang, Y.C., Kaigler, D., Rice, K.G., Krebsbach, P.H., and Mooney, D.J. Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal cell-driven bone regeneration. J Bone Miner Res 20, 848, 2005.
123. Backer, M.V., Patel, V., Jehning, B.T., Claffey, K.P., and Backer, J.M. Surface immobilization of active vascular en-dothelial growth factor via a cysteine-containing tag. Bio-materials 27, 5452, 2006.
124. Chiu, L.L., Weisel, R.D., Li, R.K., and Radisic, M. Defining conditions for covalent immobilization of angiogenic growth factors onto scaffolds for tissue engineering. J Tissue Eng Regen Med 5, 69, 2011.
125. Christman, K.L., Vazquez-Dorbatt, V., Schopf, E., Ko-lodziej, C.M., Li, R.C., Broyer, R.M., et al. Nanoscale growth factor patterns by immobilization on a heparin-mimicking polymer. J Am Chem Soc 130, 16585, 2008.
126. Masters, K.S. Covalent growth factor immobilization strategies for tissue repair and regeneration. Macromol Biosci 11, 1149, 2011.
127. Park, Y.J., Kim, K.H., Lee, J.Y., Ku, Y., Lee, S.J., Min, B.M., et al. Immobilization of bone morphogenetic protein-2 on a nanofibrous chitosan membrane for enhanced guided bone regeneration. Biotechnol Appl Biochem 43, 17, 2006.
128. Pohl, T.L., Boergermann, J.H., Schwaerzer, G.K., Knaus, P., and Cavalcanti-Adam, E.A. Surface immobilization of bone morphogenetic protein 2 via a self-assembled monolayer formation induces cell differentiation. Acta Biomater 8, 772, 2011.
129. Pompe, T., Salchert, K., Alberti, K., Zandstra, P., and Werner, C. Immobilization of growth factors on solid supports for the modulation of stem cell fate. Nat Protoc 5, 1042, 2010.
130. Sharon, J.L., and Puleo, D.A. Immobilization of glycopro-teins, such as VEGF, on biodegradable substrates. Acta Biomater 4, 1016, 2008.
131. Wang, Y., Hosta-Rigau, L., Lomas, H., and Caruso, F. Na-nostructured polymer assemblies formed at interfaces: applications from immobilization and encapsulation to stimuli-responsive release. Phys Chem Chem Phys 13, 4782, 2011.
132. Leslie-Barbick, J.E., Shen, C., Chen, C., and West, J.L. Micron-scale spatially patterned, covalently immobilized vascular endothelial growth factor on hydrogels accelerates endothelial tubulogenesis and increases cellular angiogenic responses. Tissue Eng Part A 17, 221, 2011.
133. Miyagi, Y., Chiu, L.L., Cimini, M., Weisel, R.D., Radisic, M., and Li, R.K. Biodegradable collagen patch with covalently immobilized VEGF for myocardial repair. Biomaterials 32, 1280, 2011.
134. Zisch, A.H., Schenk, U., Schense, J.C., Sakiyama-Elbert, S.E., and Hubbell, J.A. Covalently conjugated VEGF-fi-brin matrices for endothelialization. J Control Release 72, 101, 2001.
135. Yamachika, E., Tsujigiwa, H., Shirasu, N., Ueno, T., Sakata, Y., Fukunaga, J., et al. Immobilized recombinant human bone morphogenetic protein-2 enhances the phosphoryla-tion of receptor-activated Smads. J Biomed Mater Res A 88, 599, 2009.
136. Zouani, O.F., Chollet, C., Guillotin, B., and Durrieu, M.C. Differentiation of pre-osteoblast cells on poly(ethylene terephthalate) grafted with RGD and/or BMPs mimetic peptides. Biomaterials 31, 8245, 2010.
137. Zhang, H., Migneco, F., Lin, C.Y., and Hollister, S.J. Chemically-conjugated bone morphogenetic protein-2 on three-dimensional polycaprolactone scaffolds stimulates osteogenic activity in bone marrow stromal cells. Tissue Eng Part A 16, 3441, 2010.
138. Shen, H., Hu, X., Yang, F., Bei, J., and Wang, S. The bio-activity of rhBMP-2 immobilized poly(lactide-co-glycolide) scaffolds. Biomaterials 30, 3150, 2009.
139. Chiang, C.K., Chowdhury, M.F., Iyer, R.K., Stanford, W.L., and Radisic, M. Engineering surfaces for site-specific vascular differentiation of mouse embryonic stem cells. Acta Biomater 6, 1904, 2010.
140. Engstrand, T., Veltheim, R., Arnander, C., Docherty-Skogh, A.C., Westermark, A., Ohlsson, C., et al. A novel biodegradable delivery system for bone morphogenetic protein-2. Plast Reconstr Surg 121, 1920, 2008.
141. Re'em, T., Kaminer-Israeli, Y., Ruvinov, E., and Cohen, S. Chondrogenesis of hMSC in affinity-bound TGF-beta scaffolds. Biomaterials 33, 751, 2012.
142. Reyes, R., Delgado, A., Sánchez, E., Fernández, A., Her-nández, A., and Evora, C. Repair of an osteochondral defect by sustained delivery of BMP-2 or TGFb1 from a bilayered alginate-PLGA scaffold. J Tissue Eng Regen Med 2012, [Epub ahead of print]; DOI: 10.1002/term.1549
143. Lovett, M., Lee, K., Edwards, A., and Kaplan, D.L. Vascu-larization strategies for tissue engineering. Tissue Eng Part B Rev 15, 353, 2009.
144. Yuen, W.W., Du, N.R., Chan, C.H., Silva, E.A., and Mooney, D.J. Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones. Proc Natl Acad Sci USA 107, 17933, 2010.
145. Vonau, R.L., Bostrom, M.P., Aspenberg, P., and Sams, A.E. Combination of growth factors inhibits bone ingrowth in the bone harvest chamber. Clin Orthop Relat Res 243, 2001.
146. Jaklenec, A., Hinckfuss, A., Bilgen, B., Ciombor, D.M., Aaron, R., and Mathiowitz, E. Sequential release of bioac-tive IGF-I and TGF-beta 1 from PLGA microsphere-based scaffolds. Biomaterials 29, 1518, 2008.
147. Riley, C.M., Fuegy, P.W., Firpo, M.A., Shu, X.Z., Prestwich, G.D., and Peattie, R.A. Stimulation of in vivo angiogenesis using dual growth factor-loaded crosslinked glycosamino-glycan hydrogels. Biomaterials 27, 5935, 2006.
148. Elia, R., Fuegy, P.W., VanDelden, A., Firpo, M.A., Pre-stwich, G.D., and Peattie, R.A. Stimulation of in vivo an-giogenesis by in situ crosslinked, dual growth factor-loaded, glycosaminoglycan hydrogels. Biomaterials 31, 4630, 2010.
149. Chen, R.R., Silva, E.A., Yuen, W.W., and Mooney, D.J. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24, 258, 2007.
150. Freeman, I., and Cohen, S. The influence of the sequential delivery of angiogenic factors from affinity-binding algi-nate scaffolds on vascularization. Biomaterials 30, 2122, 2009.
151. Sun, Q., Silva, E.A., Wang, A., Fritton, J.C., Mooney, D.J., Schaffler, M.B., et al. Sustained release of multiple growth factors from injectable polymeric system as a novel therapeutic approach towards angiogenesis. Pharm Res 27, 264, 2010.
152. Zieris, A., Chwalek, K., Prokoph, S., Levental, K.R., Welzel, P.B., Freudenberg, U., et al. Dual independent delivery of pro-angiogenic growth factors from starPEG-heparin hy-drogels. J Control Release 156, 28, 2011.
153. Zieris, A., Prokoph, S., Levental, K.R., Welzel, P.B., Grimmer, M., Freudenberg, U., et al. FGF-2 and VEGF functio-nalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Bioma-terials 31, 7985, 2010.
154. Sun, G., Shen, Y-I., Kusuma, S., Fox-Talbot, K., Steenber-gen, C.J., and Gerecht, S. Functional neovascularization of biodegradable dextran hydrogels with multiple angiogenic growth factors. Biomaterials 32, 95, 2011.
155. Chow, L.W., Bitton, R., Webber, M.J., Carvajal, D., Shull, K.R., Sharma, A.K., et al. A bioactive self-assembled membrane to promote angiogenesis. Biomaterials 32, 1574, 2011.
156. Ekaputra, A.K., Prestwich, G.D., Cool, S.M., and Hutma-cher, D.W. The three-dimensional vascularization of growth factor-releasing hybrid scaffold of poly (epsilon-caprolactone)/collagen fibers and hyaluronic acid hydro-gel. Biomaterials 32, 8108, 2011.
157. Tengood, J.E., Ridenour, R., Brodsky, R., Russell, A.J., and Little, S.R. Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis. Tissue Eng Part A 17, 1181, 2011.
158. Zhang, W., Wang, X., Wang, S., Zhao, J., Xu, L., Zhu, C., et al. The use of injectable sonication-induced silk hydrogel for VEGF(165) and BMP-2 delivery for elevation of the maxillary sinus floor. Biomaterials 32, 9415, 2011.
159. Ratanavaraporn, J., Furuya, H., Kohara, H., and Tabata, Y. Synergistic effects of the dual release of stromal cell-derived factor-1 and bone morphogenetic protein-2 from hydrogels on bone regeneration. Biomaterials 32, 2797, 2011.
160. Reyes, R., De la Riva, B., Delgado, A., Hernandez, A., Sanchez, E., and Evora, C. Effect of triple growth factor controlled delivery by a brushite-PLGA system on a bone defect. Injury 43, 334, 2011.
161. Raiche, A.T., and Puleo, D.A. Cell responses to BMP-2 and IGF-I released with different time-dependent profiles. J Biomed Mater Res A 69, 342, 2004.
162. Raiche, A.T., and Puleo, D.A. In vitro effects of combined and sequential delivery of two bone growth factors. Bio-materials 25, 677, 2004.
163. Simmons, C.A., Alsberg, E., Hsiong, S., Kim, W.J., and Mooney, D.J. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. Bone 35, 562, 2004.
164. Oest, M.E., Dupont, K.M., Kong, H.J., Mooney, D.J., and Guldberg, R.E. Quantitative assessment of scaffold and growth factor-mediated repair of critically sized bone defects. J Orthop Res 25, 941, 2007.
165. Kempen, D.H., Lu, L., Heijink, A., Hefferan, T.E., Creemers, L.B., Maran, A., et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30, 2816, 2009.
166. De la Riva, B., Sanchez, E., Hernandez, A., Reyes, R., Tamimi, F., Lopez-Cabarcos, E., et al. Local controlled release of VEGF and PDGF from a combined brushite-chitosan system enhances bone regeneration. J Control Release 143, 45, 2010.
167. Shah, N.J., Macdonald, M.L., Beben, Y.M., Padera, R.F., Samuel, R.E., and Hammond, P.T. Tunable dual growth factor delivery from polyelectrolyte multilayer films. Bio-materials 32, 6183, 2011.
168. Kohara, H., and Tabata, Y. Enhancement of ectopic osteoid formation following the dual release of bone morphoge-netic protein 2 and Wnt1 inducible signaling pathway protein 1 from gelatin sponges. Biomaterials 32, 5726, 2011.
169. Tachi, K., Takami, M., Sato, H., Mochizuki, A., Zhao, B., Miyamoto, Y., et al. Enhancement of bone morphogenetic protein-2-induced ectopic bone formation by transforming growth factor-beta1. Tissue Eng Part A 17, 597, 2011.
170. Geuze, R.E., Theyse, L.F.H., Kempen, D.H.R., Hazewinkel, H.A.W., Kraak, H.Y.A., Oner, F.C., et al. A differential effect of bone morphogenetic protein-2 and vascular endothelial growth factor release timing on osteogenesis at ectopic and orthotopic sites in a large-animal model. Tissue Eng Part A 18, 2052, 2012.
171. Holland, T.A., Tabata, Y., and Mikos, A.G. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. J Control Release 101, 111, 2005.
172. Holland, T.A., Bodde, E.W., Cuijpers, V.M., Baggett, L.S., Tabata, Y., Mikos, A.G., et al. Degradable hydrogel scaffolds for in vivo delivery of single and dual growth factors in cartilage repair. Osteoarthritis Cartilage 15, 187, 2007.
173. Wang, X., Wenk, E., Zhang, X., Meinel, L., Vunjak-Nova-kovic, G., and Kaplan, D.L. Growth factor gradients via microsphere delivery in biopolymer scaffolds for os-teochondral tissue engineering. J Control Release 134, 81, 2009.
174. Mohan, N., Dormer, N.H., Caldwell, K.L., Key, V.H., Berkland, C.J., and Detamore, M.S. Continuous gradients of material composition and growth factors for effective regeneration of the osteochondral interface. Tissue Eng Part A 17, 2845, 2011.
175. Dormer, N.H., Singh, M., Wang, L., Berkland, C.J., and Detamore, M.S. Osteochondral interface tissue engineering using macroscopic gradients of bioactive signals. Ann Biomed Eng 38, 2167, 2010.
176. Re'em, T., Witte, F., Willbold, E., Ruvinov, E., and Cohen, S. Simultaneous regeneration of articular cartilage and subchondral bone induced by spatially presented TGF-beta and BMP-4 in a bilayer affinity binding system. Acta Bio-mater 8, 3283, 2012.
177. Calori, G.M., Donati, D., Di Bella, C., and Tagliabue, L. Bone morphogenetic proteins and tissue engineering: future directions. Injury 40 Suppl 3, S67, 2009.
178. Luong, L.N., Ramaswamy, J., and Kohn, D.H. Effects of osteogenic growth factors on bone marrow stromal cell differentiation in a mineral-based delivery system. Bioma-terials 33, 283, 2012.
179. Strobel, C., Bormann, N., Kadow-Romacker, A., Schmid-maier, G., and Wildemann, B. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. J Control Release 156, 37, 2011.
180. Choi, D.H., Park, C.H., Kim, I.H., Chun, H.J., Park, K., and Han, D.K. Fabrication of core-shell microcapsules using PLGA and alginate for dual growth factor delivery system. J Control Release 147, 193, 2010.
181. Jones, E., and Yang, X. Mesenchymal stem cells and bone regeneration: current status. Injury 42, 562, 2011.
182. Granero-Molto, F., Weis, J.A., Miga, M.I., Landis, B., Myers, T.J., O'Rear, L., et al. Regenerative effects of transplanted mesenchymal stem cells in fracture healing. Stem Cells 27, 1887, 2009.
183. Kitaori, T., Ito, H., Schwarz, E.M., Tsutsumi, R., Yoshitomi, H., Oishi, S., et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum 60, 813, 2009.
184. Mountziaris, P.M., Spicer, P.P., Kasper, F.K., and Mikos, A.G. Harnessing and modulating inflammation in strate-gies for bone regeneration. Tissue Eng Part B Rev 17, 393, 2011.
185. Phillips, J.E., Burns, K.L., Le Doux, J.M., Guldberg, R.E., and Garcia, A.J. Engineering graded tissue interfaces. Proc Natl Acad Sci USA 105, 12170, 2008.
186. Lu, H.H., and Spalazzi, J.P. Biomimetic stratified scaffold design for ligament-to-bone interface tissue engineering. Comb Chem High Throughput Screen 12, 589, 2009.
187. Li, X., Xie, J., Lipner, J., Yuan, X., Thomopoulos, S., and Xia, Y. Nanofiber scaffolds with gradations in mineral content for mimicking the tendon-to-bone insertion site. Nano Lett 9, 2763, 2009.
188. Jiang, J., Tang, A., Ateshian, G.A., Guo, X.E., Hung, C.T., and Lu, H.H. Bioactive stratified polymer ceramic-hydrogel scaffold for integrative osteochondral repair. Ann Biomed Eng 38, 2183, 2010.
189. Sherwood, J.K., Riley, S.L., Palazzolo, R., Brown, S.C., Monkhouse, D.C., Coates, M., et al. A three-dimensional osteochondral composite scaffold for articular cartilage repair. Biomaterials 23, 4739, 2002.
190. Guo, X., Park, H., Liu, G., Liu, W., Cao, Y., Tabata, Y., et al. In vitro generation of an osteochondral construct using in-jectable hydrogel composites encapsulating rabbit marrow mesenchymal stem cells. Biomaterials 30, 2741, 2009.
191. Holland, T.A., Bodde, E.W., Baggett, L.S., Tabata, Y., Mi-kos, A.G., and Jansen, J.A. Osteochondral repair in the rabbit model utilizing bilayered, degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds. J Biomed Mater Res A 75, 156, 2005.
192. Harris, B.P., Kutty, J.K., Fritz, E.W., Webb, C.K., Burg, K.J., and Metters, A.T. Photopatterned polymer brushes promoting cell adhesion gradients. Langmuir 22, 4467, 2006.
193. Seidi, A., Ramalingam, M., Elloumi-Hannachi, I., Os-trovidov, S., and Khademhosseini, A. Gradient biomateri-als for soft-to-hard interface tissue engineering. Acta Biomater 7, 1441, 2011.
194. Dormer, N.H., Singh, M., Zhao, L., Mohan, N., Berkland, C.J., and Detamore, M.S. Osteochondral interface regeneration of the rabbit knee with macroscopic gradients of bioactive signals. J Biomed Mater Res A 100, 162, 2012.
195. Lu, H.H., Subramony, S.D., Boushell, M.K., and Zhang, X. Tissue engineering strategies for the regeneration of orthopedic interfaces. Ann Biomed Eng 38, 2142, 2010.
196. Noth, U., Rackwitz, L., Steinert, A.F., and Tuan, R.S. Cell delivery therapeutics for musculoskeletal regeneration. Adv Drug Deliv Rev 62, 765, 2010.
197. Sheyn, D., Mizrahi, O., Benjamin, S., Gazit, Z., Pelled, G., and Gazit, D. Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev 62, 683, 2010.
198. Lieberman, J.R., Daluiski, A., Stevenson, S., Wu, L., McAllister, P., Lee, Y.P., et al. The effect of regional gene therapy with bone morphogenetic protein-2-producing bone-marrow cells on the repair of segmental femoral defects in rats. J Bone Joint Surg Am 81, 905, 1999.
199. Jiang, X., Gittens, S.A., Chang, Q., Zhang, X., Chen, C., and Zhang, Z. The use of tissue-engineered bone with human bone morphogenetic protein-4-modified bone-marrow stromal cells in repairing mandibular defects in rabbits. Int J Oral Maxillofac Surg 35, 1133, 2006.
200. Rose, T., Peng, H., Usas, A., Josten, C., Fu, F.H., and Huard, J. [Ex-vivo gene therapy with BMP-4 for critically sized defects and enhancement of fracture healing in an osteo-porotic animal model]. Unfallchirurg 108, 25, 2005.
201. Li, J.Z., Li, H., Sasaki, T., Holman, D., Beres, B., Dumont, R.J., et al. Osteogenic potential of five different recombinant human bone morphogenetic protein adenoviral vectors in the rat. Gene Ther 10, 1735, 2003.
202. Jane, J.A., Jr., Dunford, B.A., Kron, A., Pittman, D.D., Sasaki, T., Li, J.Z., et al. Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. Mol Ther 6, 464, 2002.
203. Varady, P., Li, J.Z., Cunningham, M., Beres, E.J., Das, S., Engh, J., et al. Morphologic analysis of BMP-9 gene therapy-induced osteogenesis. Hum Gene Ther 12, 697, 2001.
204. Steinert, A.F., Palmer, G.D., Pilapil, C., Noth, U., Evans, C.H., and Ghivizzani, S.C. Enhanced in vitro chondrogen-esis of primary mesenchymal stem cells by combined gene transfer. Tissue Eng Part A 15, 1127, 2009.
205. Chen, H.C., Chang, Y.H., Chuang, C.K., Lin, C.Y., Sung, L.Y., Wang, Y.H., et al. The repair of osteochondral defects using baculovirus-mediated gene transfer with de-differentiated chondrocytes in bioreactor culture. Biomaterials 30, 674, 2009.
206. Pagnotto, M.R., Wang, Z., Karpie, J.C., Ferretti, M., Xiao, X., and Chu, C.R. Adeno-associated viral gene transfer of transforming growth factor-beta1 to human mesenchymal stem cells improves cartilage repair. Gene Ther 14, 804, 2007.
207. Hidaka, C., Goodrich, L.R., Chen, C.T., Warren, R.F., Crystal, R.G., and Nixon, A.J. Acceleration of cartilage repair by genetically modified chondrocytes over expressing bone morphogenetic protein-7. J Orthop Res 21, 573, 2003.
208. Lu, C.H., Lin, K.J., Chiu, H.Y., Chen, C.Y., Yen, T.C., Hwang, S.M., et al. Improved chondrogenesis and engineered cartilage formation from TGF-beta 3-expressing adipose-derived stem cells cultured in the rotating-shaft bioreactor. Tissue Eng Part A 18, 2114, 2012.
209. Matsumoto, T., Cooper, G.M., Gharaibeh, B., Meszaros, L.B., Li, G., Usas, A., et al. Cartilage repair in a rat model of osteoarthritis through intraarticular transplantation of muscle-derived stem cells expressing bone morphogenetic protein 4 and soluble Flt-1. Arthritis Rheum 60, 1390, 2009.
210. Menendez, M.I., Clark, D.J., Carlton, M., Flanigan, D.C., Jia, G., Sammet, S., et al. Direct delayed human adenoviral BMP-2 or BMP-6 gene therapy for bone and cartilage regeneration in a pony osteochondral model. Osteoarthritis Cartilage 19, 1066, 2011.
211. Meinel, L., Hofmann, S., Betz, O., Fajardo, R., Merkle, H.P., Langer, R., et al. Osteogenesis by human mesenchymal stem cells cultured on silk biomaterials: comparison of adenovirus mediated gene transfer and protein delivery of BMP-2. Biomaterials 27, 4993, 2006.
212. Xiao, C., Zhou, H., Liu, G., Zhang, P., Fu, Y., Gu, P., et al. Bone marrow stromal cells with a combined expression of BMP-2 and VEGF-165 enhanced bone regeneration. Biomed Mater 6, 015013, 2011.
213. Hou, H., Zhang, X., Tang, T., Dai, K., and Ge, R. Enhancement of bone formation by genetically-engineered bone marrow stromal cells expressing BMP-2, VEGF and angiopoietin-1. Biotechnol Lett 31, 1183, 2009.
214. Klöpper, J., Lindenmaier, W., Fiedler, U., Mehlhorn, A., Stark, G.B., and Finkenzeller, G. High efficient adenoviral-mediated VEGF and Ang-1 gene delivery into osteogenically differentiated human mesenchymal stem cells. Microvasc Res 75, 83, 2008.
215. Peng, H., Wright, V., Usas, A., Gearhart, B., Shen, H.C., Cummins, J., et al. Synergistic enhancement of bone for-mation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. J Clin Invest 110, 751, 2002.
216. Zhang, Y., Shi, B., Li, C., Wang, Y., Chen, Y., Zhang, W., et al. The synergetic bone-forming effects of combinations of growth factors expressed by adenovirus vectors on chit-osan/collagen scaffolds. J Control Release 136, 172, 2009.
217. Lee, J.S., Lee, J.M., and Im, G.I. Electroporation-mediated transfer of Runx2 and Osterix genes to enhance osteogen-esis of adipose stem cells. Biomaterials 32, 760, 2011.
218. Song, K., Rao, N.J., Chen, M.L., Huang, Z.J., and Cao, Y.G. Enhanced bone regeneration with sequential delivery of basic fibroblast growth factor and sonic hedgehog. Injury 42, 796, 2011.
219. Gelse, K., von der Mark, K., Aigner, T., Park, J., and Schneider, H. Articular cartilage repair by gene therapy using growth factor-producing mesenchymal cells. Arthritis Rheum 48, 430, 2003.
220. Nixon, A.J., Haupt, J.L., Frisbie, D.D., Morisset, S.S., McIl-wraith, C.W., Robbins, P.D., et al. Gene-mediated restoration of cartilage matrix by combination insulin-like growth factor-I/interleukin-1 receptor antagonist therapy. Gene Ther 12, 177, 2005.
221. Orth, P., Kaul, G., Cucchiarini, M., Zurakowski, D., Menger, M., Kohn, D., et al. Transplanted articular chondrocytes co-overexpressing IGF-I and FGF-2 stimulate cartilage repair in vivo. Knee Surg Sports Traumatol Arthrosc 19, 2119, 2011.
222. Madry, H., Orth, P., Kaul, G., Zurakowski, D., Menger, M.D., Kohn, D., et al. Acceleration of articular cartilage repair by combined gene transfer of human insulin-like growth factor I and fibroblast growth factor-2 in vivo. Arch Orthop Trauma Surg 130, 1311, 2010.
223. Park, J.S., Yang, H.N., Woo, D.G., Jeon, S.Y., Do, H.J., Lim, H.Y., et al. Chondrogenesis of human mesenchymal stem cells mediated by the combination of SOX trio SOX5, 6, and 9 genes complexed with PEI-modified PLGA nanoparticles. Biomaterials 32, 3679, 2011.
224. Yang, H.N., Park, J.S., Woo, D.G., Jeon, S.Y., Do, H.J., Lim, H.Y., et al. Chondrogenesis of mesenchymal stem cells and dedifferentiated chondrocytes by transfection with SOX Trio genes. Biomaterials 32, 7695, 2011.
225. Zhang, F., Yao, Y., Su, K., Pang, P.X., Zhou, R., Wang, Y., et al. Redifferentiation of dedifferentiated chondrocytes by adenoviral vector-mediated TGF-beta3 and collagen-1 silencing shRNA in 3D culture. Ann Biomed Eng 39, 3042, 2011.
226. Chen, J., Chen, H., Li, P., Diao, H., Zhu, S., Dong, L., et al. Simultaneous regeneration of articular cartilage and sub-chondral bone in vivo using MSCs induced by a spatially controlled gene delivery system in bilayered integrated scaffolds. Biomaterials 32, 4793, 2011.
227. Aicher, W.K., Buhring, H.J., Hart, M., Rolauffs, B., Badke, A., and Klein, G. Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells-potential and pitfalls. Adv Drug Deliv Rev 63, 342, 2011.
228. Pirraco, R.P., Marques, A.P., and Reis, R.L. Cell interactions in bone tissue engineering. J Cell Mol Med 14, 93, 2010.
229. Sharma, B., and Elisseeff, J.H. Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng 32, 148, 2004.
230. Das, A., and Botchwey, E. Evaluation of angiogenesis and osteogenesis. Tissue Eng Part B Rev 17, 403, 2011.
231. Liu, X., Sun, H., Yan, D., Zhang, L., Lv, X., Liu, T., et al. In vivo ectopic chondrogenesis of BMSCs directed by mature chondrocytes. Biomaterials 31, 9406, 2010.
232. Anitua, E., and Orive, G. Endogenous regenerative technology using plasma-and platelet-derived growth factors. J Control Release 157, 317, 2011.
233. Anitua, E., Sanchez, M., Nurden, A.T., Nurden, P., Orive, G., and Andia, I. New insights into and novel applications for platelet-rich fibrin therapies. Trends Biotechnol 24, 227, 2006.
234. Anitua, E., Sanchez, M., and Orive, G. Potential of endogenous regenerative technology for in situ regenerative medicine. Adv Drug Deliv Rev 62, 741, 2010.
235. Gaßling, V.L.W., Açil, Y., Springer, I.N., Hubert, N., and Wiltfang, J. Platelet-rich Plasma and Platelet-rich fibrin in human cell culture. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 108, 48, 2009.
236. Blair, P., and Flaumenhaft, R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev 23, 177, 2009.
237. Mann, K.G. Biochemistry and physiology of blood coagulation. Thromb Haemost 82, 165, 1999.
238. Intini, G. The use of platelet-rich plasma in bone reconstruction therapy. Biomaterials 30, 4956, 2009.
239. Dohan Ehrenfest, D.M., Rasmusson, L., and Albrektsson, T. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte-and platelet-rich fibrin (L-PRF). Trends Biotechnol 27, 158, 2009.
240. Salvadè, A., Mina, P.D., Gaddi, D., Gatto, F., Villa, A., Bi-goni, M., et al. Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods 16, 201, 2009.
241. Schroeder, J.E., and Mosheiff, R. Tissue engineering approaches for bone repair: concepts and evidence. Injury 42, 609, 2011.
242. Wu, W., Zhang, J., Dong, Q., Liu, Y., Mao, T., and Chen, F. Platelet-rich plasma- A promising cell carrier for micro-invasive articular cartilage repair. Med Hypotheses 72, 455, 2009.
243. Mishra, A., Tummala, P., King, A., Lee, B., Kraus, M., Tse, V., et al. Buffered platelet-rich plasma enhances mesen-chymal stem cell proliferation and chondrogenic differentiation. Tissue Eng Part C Methods 15, 431, 2009.
244. Bhanot, S., and Alex, J.C. Current applications of platelet gels in facial plastic surgery. Facial Plast Surg 18, 27, 2002.
245. Mishra, A., Woodall, J., Jr., and Vieira, A. Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med 28, 113, 2009.
246. McAleer, J.P., Sharma, S., Kaplan, E.M., and Persich, G. Use of autologous platelet concentrate in a nonhealing lower extremity wound. Adv Skin Wound Care 19, 354, 2006.
247. Bertoldi, C., Pinti, M., Zaffe, D., Cossarizza, A., Consolo, U., and Ceccherelli, G.B. Morphologic, histochemical, and functional analysis of platelet-rich plasma activity on skeletal cultured cells. Transfusion 49, 1728, 2009.
248. Raghoebar, G.M., Schortinghuis, J., Liem, R.S., Ruben, J.L., van der Wal, J.E., and Vissink, A. Does platelet-rich plasma promote remodeling of autologous bone grafts used for augmentation of the maxillary sinus floor? Clin Oral Implants Res 16, 349, 2005.
249. Pryor, M.E., Polimeni, G., Koo, K.T., Hartman, M.J., Gross, H., April, M., et al. Analysis of rat calvaria defects implanted with a platelet-rich plasma preparation: histologic and histometric observations. J Clin Periodontol 32, 966, 2005.
250. Butterfield, K.J., Bennett, J., Gronowicz, G., and Adams, D. Effect of platelet-rich plasma with autogenous bone graft or maxillary sinus augmentation in a rabbit model. J Oral Maxillofac Surg 63, 370, 2005.
251. Aghaloo, T.L., Moy, P.K., and Freymiller, E.G. Investigation of platelet-rich plasma in rabbit cranial defects: a pilot study. J Oral Maxillofac Surg 60, 1176, 2002.
252. Griffin, X.L., Smith, CM., and Costa, M.L. The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. Injury 40, 158, 2009.
253. Hokugo, A., Ozeki, M., Kawakami, O., Sugimoto, K., Mushimoto, K., Morita, S., et al. Augmented bone regeneration activity of platelet-rich plasma by biodegradable gelatin hydrogel. Tissue Eng 11, 1224, 2005.
254. Araki, J., Jona, M., Eto, H., Aoi, N., Kato, H., Suga, H., et al. Optimized preparation method of platelet-concentrated plasma and noncoagulating platelet-derived factor concentrates: maximization of platelet concentration and removal of fibrinogen. Tissue Eng Part C Methods 18, 176, 2011.
255. Sanchez, A.R., Sheridan, P.J., and Kupp, L.I. Is platelet-rich plasma the perfect enhancement factor? a current review. Int J Oral Maxillofac Implants 18, 93, 2003.
256. Nikolidakis, D., and Jansen, J.A. The biology of platelet-rich plasma and its application in oral surgery: literature review. Tissue Eng Part B Rev 14, 249, 2008.
257. Cheng, M., Wang, H., Yoshida, R., and Murray, M.M. Platelets and plasma proteins are both required to stimulate collagen gene expression by anterior cruciate ligament cells in three-dimensional culture. Tissue Eng Part A 16, 1479, 2009.
258. Nair, M.B., Varma, H.K., and John, A. Platelet-rich plasma and fibrin glue-coated bioactive ceramics enhance growth and differentiation of goat bone marrow-derived stem cells. Tissue Eng Part A 15, 1619, 2009.
259. Hakimi, M., Jungbluth, P., Sager, M., Betsch, M., Herten, M., Becker, J., et al. Combined use of platelet-rich plasma and autologous bone grafts in the treatment of long bone defects in mini-pigs. Injury 41, 717, 2010.
260. Fortier, L.A., Barker, J.U., Strauss, E.J., McCarrel, T.M., and Cole, B.J. The role of growth factors in cartilage repair. Clin Orthop Relat Res 469, 2706, 2011.
261. Marx, RE. Platelet-rich plasma: evidence to support its use. J Oral Maxillofac Surg 62, 489, 2004.
262. Yamada, Y., Ueda, M., Naiki, T., Takahashi, M., Hata, K., and Nagasaka, T. Autogenous injectable bone for regeneration with mesenchymal stem cells and platelet-rich plasma: tissue-engineered bone regeneration. Tissue Eng 10, 955, 2004.
263. Sarkar, M.R, Augat, P., Shefelbine, S.J., Schorlemmer, S., Huber-Lang, M., Claes, L., et al. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. Biomaterials 27, 1817, 2006.
264. Rai, B., Oest, M.E., Dupont, K.M., Ho, K.H., Teoh, S.H., and Guldberg, R.E. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. J Biomed Mater Res A 81, 888, 2007.
265. Plachokova, A.S., van den Dolder, J., Stoelinga, P.J., and Jansen, J.A. Early effect of platelet-rich plasma on bone healing in combination with an osteoconductive material in rat cranial defects. Clin Oral Implants Res 18, 244, 2007.
266. Wu, W., Chen, F., Liu, Y., Ma, Q., and Mao, T. Autologous injectable tissue-engineered cartilage by using platelet-rich plasma: experimental study in a rabbit model. J Oral Maxillofac Surg 65, 1951, 2007.
267. Ishida, K., Kuroda, R., Miwa, M., Tabata, Y., Hokugo, A., Kawamoto, T., et al. The regenerative effects of platelet-rich plasma on meniscal cells in vitro and its in vivo application with biodegradable gelatin hydrogel. Tissue Eng 13, 1103, 2007.
268. Dutra, C.E., Pereira, M.M., Serakides, R., and Rezende, C.M. In vivo evaluation of bioactive glass foams associated with platelet-rich plasma in bone defects. J Tissue Eng Regen Med 2, 221, 2008.
269. Lu, H.H., Vo, J.M., Chin, H.S., Lin, J., Cozin, M., Tsay, R., et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A 86, 1128, 2008.
270. Bir, S.C., Esaki, J., Marui, A., Yamahara, K., Tsubota, H., Ikeda, T., et al. Angiogenic properties of sustained release platelet-rich plasma: characterization in-vitro and in the is-chemic hind limb of the mouse. J Vasc Surg 50, 870, 2009.
271. Bi, L., Cheng, W., Fan, H., and Pei, G. Reconstruction of goat tibial defects using an injectable tricalcium phos-phate/chitosan in combination with autologous platelet-rich plasma. Biomaterials 31, 3201, 2010.
272. Niemeyer, P., Fechner, K., Milz, S., Richter, W., Suedkamp, N.P., Mehlhorn, A.T., et al. Comparison of mesenchymal stem cells from bone marrow and adipose tissue for bone regeneration in a critical size defect of the sheep tibia and the influence of platelet-rich plasma. Biomaterials 31, 3572, 2010.
273. Sell, S.A., Wolfe, P.S., Ericksen, J.J., Simpson, D.G., and Bowlin, G.L. Incorporating platelet-rich plasma into elec-trospun scaffolds for tissue engineering applications. Tissue Eng Part A 17, 2723, 2011.
274. Arpornmaeklong, P., Pripatnanont, P., Kittidumkerng, W., and Mitarnun, W. Effects of autogenous growth factors on heterotopic bone formation of osteogenic cells in small animal model. J Craniomaxillofac Surg 40, 332, 2011.
275. Wu, C.C., Chen, W.H., Zao, B., Lai, P.L., Lin, T.C., Lo, H.Y., et al. Regenerative potentials of platelet-rich plasma enhanced by collagen in retrieving pro-inflammatory cyto-kine-inhibited chondrogenesis. Biomaterials 32, 5847, 2011.
276. Ozdemir, B., Kurtis, B., Tuter, G., Senguven, B., Tokman, B., Pinar-Ozdemir, S., et al. Double-application of platelet-rich plasma on bone healing in rabbits. Med Oral Patol Oral Cir Bucal 17, e171, 2012.
277. Lee, H.R., Park, K.M., Joung, Y.K., Park, K.D., and Do, S.H. Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2. J Control Release 159, 332, 2012.
278. Xie, X., Wang, Y., Zhao, C., Guo, S., Liu, S., Jia, W., et al. Comparative evaluation of MSCs from bone marrow and adipose tissue seeded in PRP-derived scaffold for cartilage regeneration. Biomaterials 33, 7008, 2012.
279. Han, B., Woodell-May, J., Ponticiello, M., Yang, Z., and Nimni, M. The effect of thrombin activation of platelet-rich plasma on demineralized bone matrix osteoinductivity. J Bone Joint Surg Am 91, 1459, 2009.
280. Arnoczky, S.P., Delos, D., and Rodeo, S.A. What is platelet-rich plasma? 19, 142, 2011.
281. Wirz, S., Dietrich, M., Flanagan, T.C., Bokermann, G., Wagner, W., Schmitz-Rode, T., et al. Influence of platelet-derived growth factor-AB on tissue development in autologous platelet-rich plasma gels. Tissue Eng Part A 17, 1891, 2011.
282. Zaky, S.H., Ottonello, A., Strada, P., Cancedda, R., and Mastrogiacomo, M. Platelet lysate favours in vitro expansion of human bone marrow stromal cells for bone and cartilage engineering. J Tissue Eng Regen Med 2, 472, 2008.
283. Kim, E.S., Kim, J.J., and Park, E.J. Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material. J Adv Prosthodont 2, 7, 2010.
284. Spicer, P.P., and Mikos, A.G. Fibrin glue as a drug delivery system. J Control Release 148, 49, 2010.
285. Iqbal, J., Pepkowitz, S.H., and Klapper, E. Platelet-rich plasma for the replenishment of bone. Curr Osteoporos Rep 9, 258, 2011.
286. Hu, Z.M., Peel, S.A., Ho, S.K., Sandor, G.K., and Clokie, C.M. Comparison of platelet-rich plasma, bovine BMP, and rhBMP-4 on bone matrix protein expression in vitro. Growth Factors 27, 280, 2009.
287. Kajikawa, Y., Morihara, T., Sakamoto, H., Matsuda, K., Oshima, Y., Yoshida, A., et al. Platelet-rich plasma enhances the initial mobilization of circulation-derived cells for tendon healing. J Cell Physiol 215, 837, 2008.
288. Lyras, D., Kazakos, K., Verettas, D., Polychronidis, A., Simopoulos, C., Botaitis, S., et al. Immunohistochemical study of angiogenesis after local administration of platelet-rich plasma in a patellar tendon defect. Int Orthop 34, 143, 2010.
289. Haberhauer, M., Zernia, G., Deiwick, A., Pösel, C., Bader, A., Huster, D., et al. Cartilage tissue engineering in plasma and whole blood scaffolds. Adv Mater 20, 2061, 2008.
290. Marx, R.E., Carlson, E.R., Eichstaedt, R.M., Schimmele, S.R., Strauss, J.E., and Georgeff, K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol 85, 638, 1998.
291. Santo, V.E., Duarte, A.R., Popa, E.G., Gomes, M.E., Mano, J.F., and Reis, R.L. Enhancement of osteogenic differentiation of human adipose derived stem cells by the controlled release of platelet lysates from hybrid scaffolds produced by supercritical fluid foaming. J Control Release 162, 19, 2012.
292. Santo, V.E., Gomes, M.E., Mano, J.F., and Reis, R.L. Chit-osan- chondroitin sulphate nanoparticles for controlled delivery of platelet lysates in bone regenerative medicine. J Tissue Eng Regen Med 6 Suppl 3, S47, 2012.
293. Visser, L.C., Arnoczky, S.P., Caballero, O., Kern, A., Rat-cliffe, A., and Gardner, K.L. Growth factor-rich plasma increases tendon cell proliferation and matrix synthesis on a synthetic scaffold: an in vitro study. Tissue Eng Part A 16, 1021, 2010.
294. Intini, G., Andreana, S., Intini, F.E., Buhite, R.J., and Bobek, L.A. Calcium sulfate and platelet-rich plasma make a novel osteoinductive biomaterial for bone regeneration. J Transl Med 5, 13, 2007.
295. Kon, E., Buda, R., Filardo, G., Di Martino, A., Timoncini, A., Cenacchi, A., et al. Platelet-rich plasma: intra-articular knee injections produced favorable results on degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc 18, 472, 2010.
296. Akeda, K., An, H.S., Okuma, M., Attawia, M., Miyamoto, K., Thonar, E.J., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 14, 1272, 2006.
297. Sampson, S., Reed, M., Silvers, H., Meng, M., and Man-delbaum, B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 89, 961, 2010.
298. Milano, G., Sanna Passino, E., Deriu, L., Careddu, G., Manunta, L., Manunta, A., et al. The effect of platelet rich plasma combined with microfractures on the treatment of chondral defects: an experimental study in a sheep model. Osteoarthritis Cartilage 18, 971, 2010.
299. Calori, G.M., Tagliabue, L., Gala, L., d'Imporzano, M., Peretti, G., and Albisetti, W. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. Injury 39, 1391, 2008.
300. Dallari, D., Savarino, L., Stagni, C., Cenni, E., Cenacchi, A., Fornasari, P.M., et al. Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. J Bone Joint Surg Am 89, 2413, 2007.
301. Doucet, C., Ernou, I., Zhang, Y., Llense, J.R., Begot, L., Holy, X., et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol 205, 228, 2005.
302. Kocaoemer, A., Kern, S., Kluter, H., and Bieback, K. Human AB serum and thrombin-activated platelet-rich plasma are suitable alternatives to fetal calf serum for the expansion of mesenchymal stem cells from adipose tissue. Stem Cells 25, 1270, 2007.
303. Avanzini, M.A., Bernardo, M.E., Cometa, A.M., Perotti, C., Zaffaroni, N., Novara, F., et al. Generation of mesenchymal stromal cells in the presence of platelet lysate: a phenotypic and functional comparison of umbilical cord blood-and bone marrow-derived progenitors. Haematologica 94, 1649, 2009.
304. Salvade, A., Della Mina, P., Gaddi, D., Gatto, F., Villa, A., Bigoni, M., et al. Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. Tissue Eng Part C Methods 16, 201, 2010.
305. Kruger, J.P., Hondke, S., Endres, M., Pruss, A., Siclari, A., and Kaps, C. Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human sub-chondral progenitor cells. J Orthop Res 30, 845, 2011.
306. Hildner, F., Albrecht, C., Gabriel, C., Redl, H., and van Griensven, M. State of the art and future perspectives of articular cartilage regeneration: a focus on adipose-derived stem cells and platelet-derived products. J Tissue Eng Re-gen Med 5, e36, 2011.
307. Park, E.J., Kim, E.S., Weber, H.P., Wright, R.F., and Mooney, D.J. Improved bone healing by angiogenic factor-enriched platelet-rich plasma and its synergistic enhancement by bone morphogenetic protein-2. Int J Oral Max-illofac
308. Schuckert, K-H., Jopp, S., and Teoh, S-H. Mandibular defect reconstruction using three-dimensional polycaprolactone scaffold in combination with platelet-rich plasma and recombinant human bone morphogenetic protein-2: de novo synthesis of bone in a single case. Tissue Eng Part A 15, 493, 2008.
309. Cenni, E., Avnet, S., Fotia, C., Salerno, M., and Baldini, N. Platelet-rich plasma impairs osteoclast generation from human precursors of peripheral blood. J Orthop Res 28, 792, 2010.
310. Luo, T., Zhang, W., Shi, B., Cheng, X., and Zhang, Y. Enhanced bone regeneration around dental implant with bone morphogenetic protein 2 gene and vascular endo-thelial growth factor protein delivery. Clin Oral Implant Res 23, 467, 2011.
311. Kirkpatrick, C.J., Fuchs, S., and Unger, R.E. Co-culture systems for vascularization-learning from nature. Adv Drug Deliv Rev 63, 291, 2011.
312. Santos, M.I., and Reis, R.L. Vascularization in bone tissue engineering: physiology, current strategies, major hurdles and future challenges. Macromol Biosci 10, 12, 2010.
313. van der Worp, H.B., Howells, D.W., Sena, E.S., Porritt, M.J., Rewell, S., O'Collins, V., et al. Can animal models of disease reliably inform human studies? PLoS Med 7, e1000245, 2010.
314. Malkesman, O., Austin, D.R., Chen, G., and Manji, H.K. Reverse translational strategies for developing animal models of bipolar disorder. Dis Model Mech 2, 238, 2009.
315. Chen, F.M., Zhao, Y.M., Zhang, R., Jin, T., Sun, H.H., Wu, Z.F., et al. Periodontal regeneration using novel glycidyl methacrylated dextran (Dex-GMA)/gelatin scaffolds containing microspheres loaded with bone morphogenetic proteins. J Control Release 121, 81, 2007.
316. Chrastina, A., Massey, K.A., and Schnitzer, J.E. Overcoming in vivo barriers to targeted nanodelivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol 3, 421, 2011.
317. Shi, J., Votruba, A.R., Farokhzad, O.C., and Langer, R. Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett 10, 3223, 2010.
318. Santo, V.E., Gomes, M.E., Mano, J.F., and Reis, R.L. From nano-to macro-scale: nanotechnology approaches for spatially controlled delivery of bioactive factors for bone and cartilage engineering. Nanomedicine 7, 1045, 2012.
319. Villa, C., Erratico, S., Razini, P., Farini, A., Meregalli, M., Belicchi, M., et al. In vivo tracking of stem cell by nano-technologies: future prospects for mouse to human translation. Tissue Eng Part B Rev 17, 1, 2011.
320. Weissleder, R., and Pittet, M.J. Imaging in the era of molecular oncology. Nature 452, 580, 2008.
321. Pivonka, P., and Dunstan, C.R. Role of mathematical modeling in bone fracture healing. BoneKEy Rep 1, 2012.
322. Wang, S., Kim, G., Lee, Y.E., Hah, H.J., Ethirajan, M., Pandey, R.K., et al. Multifunctional biodegradable poly-acrylamide nanocarriers for cancer theranostics- A "see and treat" strategy. ACS Nano 6, 6843, 2012.
323. Baum, R.P., Kulkarni, H.R., and Carreras, C. Peptides and receptors in image-guided therapy: theranostics for neu-roendocrine neoplasms. Semin Nucl Med 42, 190, 2012.
324. Xie, J., and Jon, S. Magnetic nanoparticle-based ther-anostics. Theranostics 2, 122, 2012.
325. Haidar, Z.S., Hamdy, R.C., and Tabrizian, M. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: current challenges in BMP delivery. Biotechnol Lett 31, 1817, 2009.
326. Boerckel, J.D., Kolambkar, Y.M., Dupont, K.M., Uhrig, B.A., Phelps, E.A., Stevens, H.Y., et al. Effects of protein dose and delivery system on BMP-mediated bone regeneration. Biomaterials 32, 5241, 2011.
327. Guldberg, R.E. Spatiotemporal delivery strategies for promoting musculoskeletal tissue regeneration. J Bone Miner Res 24, 1507, 2009.
328. Chen, F.M., Zhang, J., Zhang, M., An, Y., Chen, F., and Wu, Z.F. A review on endogenous regenerative technology in periodontal regenerative medicine. Biomaterials 31, 7892, 2010.
329. Lin, C.C., and Anseth, K.S. PEG hydrogels for the controlled release of biomolecules in regenerative medicine. Pharm Res 26, 631, 2009.
330. Kwon, K.W., Park, H., Song, K.H., Choi, J.C., Ahn, H., Park, M.J., et al. Nanotopography-guided migration of T cells. J Immunol 189, 2266, 2012.
331. Lopacinska, J.M., Gradinaru, C., Wierzbicki, R., Kobler, C., Schmidt, M.S., Madsen, M.T., et al. Cell motility, morphology, viability and proliferation in response to nanoto-pography on silicon black. Nanoscale 4, 3739, 2012.
332. Choi, J.S., and Yoo, H.S. Nano-inspired fibrous matrix with bi-phasic release of proteins. J Nanosci Nanotechnol 10, 3038, 2010.
333. Custodio, C.A., Frias, A.M., Del Campo, A., Reis, R.L., and Mano, J.F. Selective cell recruitment and spatially controlled cell attachment on instructive chitosan surfaces functionalized with antibodies. Biointerphases 7, 65, 2012.
334. Nakanishi, H., Walker, D.A., Bishop, K.J.M., Wesson, P.J., Yan, Y., Soh, S., et al. Dynamic internal gradients control and direct electric currents within nanostructured materials. Nat Nanotechnol 6, 740, 2011.
335. Wang, P.Y., Tsai, W.B., and Voelcker, N.H. Screening of rat mesenchymal stem cell behaviour on polydimethylsiloxane stiffness gradients. Acta Biomater 8, 519, 2012.
336. Webber, M.J., Matson, J.B., Tamboli, V.K., and Stupp, S.I. Controlled release of dexamethasone from peptide nanofi-ber gels to modulate inflammatory response. Biomaterials 33, 6823, 2012.
337. Sargeant, T.D., Aparicio, C., Goldberger, J.E., Cui, H.G., and Stupp, S.I. Mineralization of peptide amphiphile na-nofibers and its effect on the differentiation of human mesenchymal stem cells. Acta Biomater 8, 2456, 2012.
338. Costa, R.R., Custodio, C.A., Arias, F.J., Rodriguez-Cabello, J.C., and Mano, J.F. Layer-by-layer assembly of chitosan and recombinant biopolymers into biomimetic coatings with multiple stimuli-responsive properties. Small 7, 2640, 2011. 339.
339. Soike, T., Streff, A.K., Guan, C.X., Ortega, R., Tantawy, M., Pino, C., et al. Engineering a material surface for drug delivery and imaging using layer-by-layer assembly of func-tionalized nanoparticles. Adv Mater 22, 1392, 2010.